Multiple Sclerosis & Cellular Research Overview
Advanced immunomodulatory and neuroprotective protocols targeting autoimmune myelin damage in India:
Pathophysiology & Neural Conduction
Multiple Sclerosis (MS) is an autoimmune and neurodegenerative condition where the immune system damages the protective myelin sheath surrounding nerve fibers in the central nervous system. This causes disrupted neural signaling, chronic fatigue, muscle spasticity, and mobility challenges.
Cellular Protocol Objectives
Specialized medical teams in India evaluate international patients for advanced, supportive cellular protocols—including mesenchymal stem cell (MSC) protocols under clinical research frameworks. These interventions aim to recalibrate immune activity, modulate inflammation, and support neural tissue preservation alongside conventional disease-modifying therapies (DMTs).
Source Distinctions, Donor Screening Rigor & Candidacy
Certified cleanroom harvesting, pathogen testing, and strict neurological screening:
Autologous Cells
Autologous Cells: Harvested from the patient’s own bone marrow or adipose tissue; eliminates foreign immunological reactions but requires an invasive collection procedure.
Allogeneic Umbilical Cord Tissue
Allogeneic Umbilical Cord Tissue: Screened donor tissue processed in ISO Class 5 cleanrooms.
Mandatory Donor Safety Testing
Mandatory Donor Safety Testing: Every donor batch undergoes mandatory molecular screening for HIV 1 & 2, Hepatitis B (HBV), Hepatitis C (HCV), Syphilis (VDRL), Cytomegalovirus (CMV), and Human T-lymphotropic virus (HTLV 1/2).
Cellular Quality Release
Cellular Quality Release: Documented post-thaw viability exceeding 90%, sterility cultures (zero bacterial/fungal growth), and negative endotoxin testing (LAL test).
Candidate Selection & Pre-Screening Criteria
Patient safety drives our screening protocol. International candidates undergo structured pre-screening prior to travel:
Confirmed Diagnosis
Confirmed Diagnosis: Clinically definite Relapsing-Remitting MS (RRMS) or active Secondary Progressive MS (SPMS) documented by a neurologist.
Disease Activity
Disease Activity: Documented inflammatory activity (recent relapses or gadolinium-enhancing MRI lesions) despite standard DMTs.
Disability Status: Baseline EDSS score typically between 2.0 and 6.0 (patients capable of walking at least short distances with or without unilateral assistance).
Systemic Health Clearance: Stable cardiac, pulmonary, renal, and hepatic function; negative screening for active systemic infections.
Exclusion Criteria (Non-Eligible)
Exclusions: Severe non-ambulatory disability (EDSS > 7.0), uncontrolled chronic infections, active cancer, or severe organ failure.
Monitored Functional Goals & Clinical Follow-Up
Clinical follow-up tracks changes over 3 to 12 months using the Expanded Disability Status Scale (EDSS):
Reduced Relapse Frequency
Reduced Relapse Frequency: Decrease or cessation in clinical flare-ups and new inflammatory lesions on follow-up MRI scans.
Mobility & Ambulation
Mobility & Ambulation: Steadier gait, better walking endurance, and improved balance with fewer balance-related falls.
Spasticity & Muscle Tone
Spasticity & Muscle Tone: Less muscle stiffness and fewer involuntary spasms, leading to smoother joint movement.
Fatigue Management
Fatigue Management: Noticeable relief from chronic MS fatigue and restored daytime physical stamina.
Sensory & Nerve Function
Sensory & Nerve Function: Gradual reduction in numbness, tingling sensations, or neuropathic pain.
Bladder & Bowel Control
Bladder & Bowel Control: Better pelvic floor coordination, reducing urgency and incontinence issues.
Why Choose Our Partner Centers in India?
Internationally certified medical infrastructure, expert neurological boards, and transparent healthcare delivery:
JCI & NABH Accredited Hospitals
JCI & NABH Accredited Hospitals: All procedures occur in globally certified tertiary hospitals with 24/7 intensive care units and infection-control standards.
cGMP Cleanroom Processing
cGMP Cleanroom Processing: Strict cellular quality standards ensure verified cell counts, viability, and sterility without contamination risks.
Multidisciplinary Neurological Board
Multidisciplinary Neurological Board: Neurologists, hematologists, physiatrists, and pain specialists collaborate on every case.
Transparent, High-Value Care
Transparent, High-Value Care: High-caliber care packages at lower cost compared to private Western facilities.
Continuity of Care
Continuity of Care: Structured remote follow-up at 1, 3, 6, and 12 months in coordination with your domestic physician.
Treatment Cost Breakdown: India vs. International Centers
Transparent financial disclosures with zero hidden charges. High-caliber neuro-regenerative care at a fraction of Western costs:
Dedicated Services for International MS Patients
Comprehensive concierge assistance from pre-travel medical clearance through discharge:
Pre-Travel File Evaluation
Pre-Travel File Evaluation: Complimentary review of recent MRIs and neurological reports by an Indian specialist before you book travel.
Medical Visa (M-Visa) Support
Medical Visa (M-Visa) Support: Official hospital invitation letters provided to expedite embassy clearance for you and your companion.
Dedicated Care Coordinator
Dedicated Care Coordinator: A single point of contact assisting you 24/7 with hospital coordination, schedules, and daily requests.
Multilingual Translation
Multilingual Translation: Dedicated interpreters available for Arabic, Russian, French, and Spanish.
Logistics & Senior-Friendly Accommodations
Wheelchair accessibility, companion comfort, and barrier-free hospital hospitality:
Accessible Airport Transfers
Accessible Airport Transfers: Private wheelchair-accessible vehicle pickups and drop-offs directly at the airport terminal.
Nearby Curated Lodging
Nearby Curated Lodging: Preferred rates at vetted 4-star and 5-star partner hotels or serviced apartments within 10 minutes of the hospital.
Accessibility Features
Accessibility Features: Step-free entrances, roll-in showers, tailored dietary meal options, and on-demand nursing care.
Chauffeur Transit
Chauffeur Transit: Daily private transfers between your accommodation and hospital appointments.
Structured 5- to 7-Day Inpatient Clinical Pathway
A multidisciplinary neurological pathway from initial hospital reception to discharge:
Clinical Notice, Patient Safety & Regulatory Framework
Important Advisory for Patients & Families:
Mandatory Regulatory & Legal Notice
Stem cell therapies for Multiple Sclerosis (excluding standard bone marrow transplants for designated hematological conditions) are classified as investigational and supportive protocols under guidelines set by the Indian Council of Medical Research (ICMR) and international neurology associations. Stem cell protocols do not constitute a definitive cure and should not replace essential prescribed disease-modifying therapies (DMTs) without explicit guidance from your treating neurologist. Candidacy is determined strictly on individual clinical merit following board review. Always consult your primary home neurologist before scheduling cross-border medical travel.
Content reviewed by licensed Neurologists and Regenerative Medicine Specialists affiliated with NABH/JCI-accredited tertiary care networks, India.
Frequently Asked Questions: Multiple Sclerosis Stem Cell Therapy
Transparent clinical answers to common patient questions regarding neuro-regenerative MS protocols:
Instead of just managing your daily flare-ups, stem cells work to gently reset your immune system so it stops attacking your central nervous system. This therapy also releases healing proteins that encourage the repair of damaged myelin, helping to improve your daily nerve function.
While it is not a permanent cure, this treatment is highly effective at halting disease progression and preventing future neurological relapses. Many patients experience a profound, long-term stabilization of their symptoms, allowing them to confidently regain control over their daily lives.
Yes, we utilize carefully screened adult stem cells, making the procedure minimally invasive and exceptionally safe compared to heavy chemical immunosuppressants. Clinical trials consistently show that the treatment is well-tolerated and focuses entirely on supporting your body's natural cellular healing.
Many patients begin to notice a comforting drop in chronic fatigue, muscle stiffness, and brain fog within the first 3 to 6 months. Because the stem cells are actively repairing delicate nerve pathways behind the scenes, these positive physical changes develop steadily over time.
Patients living with relapsing-remitting MS (RRMS) or active progressive MS tend to see the most remarkable, life-changing benefits from this therapy. Our neurology specialists will carefully review your latest MRI scans and medical history to ensure this is the safest, most effective path forward for you.
You should always consult with your neurologist before making changes, but many patients successfully reduce their reliance on daily disease-modifying therapies after treatment. The stem cells act as a powerful biological reset, working beautifully right alongside your standard neurological care.
Scientific Evidence & Peer-Reviewed Literature
Our clinical protocols are informed by published international clinical trials evaluating cellular therapies in Multiple Sclerosis: